Family · Pharmaceutical analytical standards
Oxymetazoline
A nasal decongestant of the imidazoline family that narrows blood vessels by stimulating alpha-adrenergic receptors; it was developed in Germany in 1961 by Wolfgang Fruhstorfer and Helmut Müller-Calgan. This family brings together the active ingredient, pharmacopoeial impurities, metabolites, labelled standards, nitrosamines and other impurities.
Did you know?The same ingredient that clears a blocked nose has been approved in the United States as a cream for rosacea redness (2017) and as eye drops to lift a drooping eyelid (2020).
No product matches your search.
EDQM standards 2
The official European Pharmacopoeia standards for this family.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
